SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about press release

08 Apr 2025 Evaluate
Lyka Labs has informed that the Company has been granted a patent for Indian Patent for its proprietary product, ‘Pregabalin Gel 8%’ by Patent Office India. A copy of the press release issued by the Company in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

65.10 0.00 (0.00%)
11-May-2026 09:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1851.90
Dr. Reddys Lab 1273.00
Cipla 1332.95
Zydus Lifesciences 933.90
Lupin 2245.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×